<DOC>
	<DOCNO>NCT02906514</DOCNO>
	<brief_summary>Best prim cardiopulmonary bypass cardiac surgery unknown . Efficacy toxicity Hydroxyethyl Starch 130/0.4 use context uncertain . The aim pilot study determine Hydroxyethyl Starch 130/0.4 effective Sodium Chloride 0.9 % short term hemodynamic purpose without side renal hemostatic effect .</brief_summary>
	<brief_title>Priming Cardiopulmonary Bypass With Hydroxyethyl Starch 130/0.4 Sodium Chloride 0.9 % : Pilot Study Adult Elective Conventional Cardiac Surgery</brief_title>
	<detailed_description />
	<mesh_term>Hydroxyethyl Starch Derivatives</mesh_term>
	<criteria>Patients schedule elective conventional cardiac surgery cardiopulmonary bypass Patients insured French social security system Pregnancy Patients place guardianship Urgent surgery Cardiac surgery without cardiopulmonary bypass Anterior cardiac surgery Non conventional cardiac surgery ( miniinvasive surgery , dual valve replacement , right heart surgery ) Simultaneous inclusion another study potential interference outcome Heparininduced thrombocytopenia Chronic renal insufficiency ( glomerular filtration rate &lt; 60mL.min1.m2 ) Nature/nurture hemostasis disorder , particular Von Willebrand disease hemophilia Hydroxyethyl Starch allergy Weight 33 kg Mechanical hemodynamic support end surgery</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Hydroxyethyl Starch</keyword>
	<keyword>Cardiac surgery</keyword>
	<keyword>Priming cardiopulmonary bypass</keyword>
</DOC>